Patents


Nature Biotechnology 25, 1105 - 1106 (2007)
doi:10.1038/nbt1007-1105

Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents

Rachel Teitelbaum1 & Mark Cohen1


A recent Supreme Court decision has introduced some uncertainty regarding the determination of obviousness of an invention.

Top
  1. Rachel Teitelbaum and Mark Cohen are at Pearl Cohen Zedek Latzer LLP, 1500 Broadway, 12th Floor, New York, New York 10036, USA. e-mail: rachelt@pczlaw.com

Extra navigation

naturejobs

natureproducts


ADVERTISEMENT